Eucrates Biomedical Acquisition Corp. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2020 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Eucrates Biomedical Acquisition Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2020 to Q4 2022.
  • Eucrates Biomedical Acquisition Corp. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2022 was $142K, a 43.1% decline year-over-year.
  • Eucrates Biomedical Acquisition Corp. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2022 was $2.42M, a 36.7% decline year-over-year.
  • Eucrates Biomedical Acquisition Corp. annual Net Income (Loss) Attributable to Parent for 2022 was $2.42M, a 36.7% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $142K -$108K -43.1% Dec 31, 2022 10-K 2023-04-13
Q3 2022 $521K -$429K -45.1% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $432K -$199K -31.5% Jun 30, 2022 10-Q 2022-11-14
Q1 2022 $1.32M -$669K -33.6% Mar 31, 2022 10-Q 2022-11-14
Q4 2021 $249K +$5.17M Dec 31, 2021 10-K 2023-04-13
Q3 2021 $950K +$953K Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $631K Jun 30, 2021 10-Q 2022-11-14
Q1 2021 $1.99M Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$4.92M Dec 31, 2020 10-K 2022-04-11
Q3 2020 -$3.08K Sep 30, 2020 10-Q 2021-11-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.